Literature DB >> 21145767

Homozygous familial hypercholesterolemia in Lebanon: a genotype/phenotype correlation.

Akl C Fahed1, Raya M Safa, Fadi F Haddad, Fadi F Bitar, Rabih R Andary, Mariam T Arabi, Sami T Azar, Georges Nemer.   

Abstract

Familial hypercholesterolemia (FH) is an inherited disease characterized by the deposition of LDL in tissues causing premature atherosclerosis. Many genes are implicated in FH resulting in a large variability in the phenotype. DNA sequencing of the LDLR gene was done for forty patients clinically diagnosed with homozygous FH and forty family members variably affected. Patients underwent noninvasive heart and vascular studies. Statistical and pedigree analyses were used to correlate the different genotypes with the phenotypes. The prevalence of homozygosity at the Lebanese allele (2043C>A) is 45%. However, 27.5% of the patients have no mutations at all in the LDLR gene, and 27.5% are either heterozygous for the 2043C>A mutation, heterozygous for a mutation in another exon of the LDLR gene, or combined heterozygous for two different mutations. We confirm previous reports on the higher prevalence of FH in Lebanon. Our results do, however contradict previous reports on an assumed higher prevalence among the Christian Lebanese. Mutations in the LDLR especially combined heterozygosity can cause a severe phenotype similar to the homozygous mutation in the Lebanese allele. This information is particularly important in targeting the more prevalent heterozygotes in the general population with early diagnosis and intervention.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145767     DOI: 10.1016/j.ymgme.2010.11.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  16 in total

1.  The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia.

Authors:  Akl C Fahed; Fadi F Bitar; Ruby I Khalaf; Elie M Moubarak; Sami T Azar; Georges M Nemer
Journal:  Endocrine       Date:  2012-04-10       Impact factor: 3.633

Review 2.  Familial hypercholesterolemia: developments in diagnosis and treatment.

Authors:  Gerald Klose; Ulrich Laufs; Winfried März; Eberhard Windler
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

Review 3.  The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.

Authors:  Faisal Alallaf; Fatima Amanullah H Nazar; Majed Alnefaie; Adel Almaymuni; Omran Mohammed Rashidi; Khalid Alhabib; Fahad Alnouri; Mohamed-Nabil Alama; Mohammad Athar; Zuhier Awan
Journal:  Open Cardiovasc Med J       Date:  2017-07-26

Review 4.  Genetics of familial hypercholesterolemia.

Authors:  Ariel Brautbar; Emili Leary; Kristen Rasmussen; Don P Wilson; Robert D Steiner; Salim Virani
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

5.  Familial hypercholesterolemia: the lipids or the genes?

Authors:  Akl C Fahed; Georges M Nemer
Journal:  Nutr Metab (Lond)       Date:  2011-04-22       Impact factor: 4.169

6.  NKX2-5 mutations in an inbred consanguineous population: genetic and phenotypic diversity.

Authors:  Ossama K Abou Hassan; Akl C Fahed; Manal Batrawi; Mariam Arabi; Marwan M Refaat; Steven R DePalma; J G Seidman; Christine E Seidman; Fadi F Bitar; Georges M Nemer
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

Review 7.  Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia.

Authors:  Alpo Vuorio; Matti J Tikkanen; Petri T Kovanen
Journal:  Vasc Health Risk Manag       Date:  2014-05-06

8.  Pregnancy in a woman with homozygous familial hypercholesterolemia not on low-density lipoprotein apheresis.

Authors:  Akl C Fahed; Anwar H Nassar
Journal:  AJP Rep       Date:  2012-02-22

9.  Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey.

Authors:  S Walzer; K Travers; S Rieder; E Erazo-Fischer; D Matusiewicz
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-03

Review 10.  Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.

Authors:  Damon A Bell; Amanda J Hooper; Gerald F Watts; John R Burnett
Journal:  Vasc Health Risk Manag       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.